Ischemic Heart Disease Drugs Market Trends, Size, Forecast - 2018-2023

Ischemic Heart Disease Market is expected to grow at a moderate rate during the forecast period 2018-2023. Ischemic heart disease, also known as CHD (coronary heart diseases) and CAD (coronary artery disease) is caused by defect and damage in the heart. Silent ischemia is one of the most prevailing ischemic diseases across the globe, caused by heart attack without prior warning. Moreover, the people having previous heart attacks or have diabetes are more prone to silent ischemia. Unhealthy dietary habits such as excessive consumption of alcohol & tobacco and lack of exercise increase the risk of ischemic heart diseases around the globe.

Request a free sample of our report on Ischemic Heart Disease Drugs Market: https://www.omrglobal.com/request-sample/ischemic-heart-disease-market

Various pivotal factors that are augmenting the ischemic heart disease market includes growing incidence and prevalence rate of hypertension, high cholesterol, diabetes, and obesity across the globe. Government funding for diagnosis, treatment and research and their initiative programs to increase the awareness toward disease is another major factor augmenting the growth of the market. However, the high costs of treatment coupled with the regular uncertainty seen in reimbursement policies can hamper the growth of the market. Opportunities that are expected to augment the market includes increasing awareness among people towards the heart diseases and improving healthcare system and healthcare spending in emerging economies.

A full report of Ischemic Heart Disease Drugs Market Is available at https://www.omrglobal.com/industry-reports/ischemic-heart-disease-market

Global Ischemic Heart Diseases Market Segmentation

By Disease Type
• Angina
• Myocardial Infarction
• Ischemic Stroke

By Diagnosis Method
• Electrocardiogram (ECG)
• Echocardiogram
• Chest X-Ray
• Cardiac Catheterization
• Coronary Angiogram

By Treatment
• Medication
o NSAID
o Statins
o Beta Blocker
o Calcium Channel Blocker
o ACE Inhibitors
o Others (Organic Nitrates)

• Surgery
o Coronary Stent
o Angioplasty

COMPETITIVE LANDSCAPE
• Key Strategy Analysis
• Key Company Analysis

REGIONAL ANALYSIS

• North America
o United States
o Canada

• Europe
o UK
o Germany
o Italy
o Spain
o France
o RoE

• Asia-Pacific
o India
o China
o Japan
o Rest of Asia-Pacific

• Rest of the World (RoW)

COMPANY PROFILES
• Abbott Laboratories
• Amgen Inc.
• AstraZeneca PLC
• Bayer AG
• Boston Scientific Corp.
• Cardinal Health, Inc.
• Daiichi Sankyo Co. Ltd.
• Edwards Lifesciences Corp.
• General Electric Co.
• Genentech, Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/ischemic-heart-disease-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Us:
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.